Compare ARK Genomic Revolution ETF (ARKG) vs Carnival Corp (CCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Carnival Corp — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Carnival Corp trades at $26.49 (market cap $36.75B). The key difference: Carnival Corp pays a 1.68% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Carnival Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | CCL | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $33.99 |
52-Week Low | $23.09 | $23.89 |
Market Cap | — | $36.75B |
Enterprise Value | — | $60.67B |
Dividend Yield | — | 1.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Carnival (CCL) trades at $26.83, up 0.41% on the day, with a bullish fundamental recovery story supported by three consecutive quarterly EPS beats. The stock shows a bearish technical signal but strong valuation metrics including a P/E of 12.09 and ROE of 26.72%. Recent news highlights the launch of the new Carnival Destiny ship and a declared $0.15 dividend, reinforcing growth initiatives.
Outlook remains positive with analyst consensus at Buy (59.57%) and a $35 price target, though risks include geopolitical tensions impacting oil prices and European demand softness. Net income margin improved to 11.24% in 2025, with debt reduction trends supporting financial health. The stock offers upside potential if operational momentum and cost controls persist amid industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Carnival Corp
Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.
Read more on CCL →
